Beyond the Brain: Heart, Lung, and Systemic Health

While Periventricular Nodular Heterotopia (PVNH) is primarily a brain malformation, certain types—especially those caused by the FLNA gene—can affect other systems in the body ^[1]. This is because the filamin A protein is used not just in the brain, but also in the heart, lungs, and blood vessels ^[2]. Understanding these “extraneurological” (outside the brain) risks is a vital part of long-term care, but it is important to note that cardiovascular and pulmonary surveillance is generally reserved for patients with a confirmed or strongly suspected genetic syndrome, not everyone with isolated PVNH.

Cardiovascular Health and the Aorta

The most critical system to monitor outside the brain is the cardiovascular system. In a specific clinical cohort of 114 people with FLNA loss-of-function variants, nearly 65% had some form of heart or blood vessel abnormality ^[1]. It is important to know these estimates come from a particular selected group, not a prediction that every person with PVNH will have an event.

• Aortic Aneurysm and Dilation: About 18% of people with FLNA mutations in that cohort develop a thoracic aortic aneurysm or dilation, which is a weakening or bulging of the large artery that carries blood from the heart ^[1]. This most often happens at the aortic root, near the heart ^[1][3].
• The Rupture Risk: A critical finding in FLNA research is that the aorta can sometimes tear (dissect) or rupture at smaller dimensions than what is considered standard for intervention in other conditions ^[1]. Because of this, management and surgical thresholds must be individualized by an aortopathy specialist using current guidelines and available evidence, considering growth rate, body size, anatomy, and family history ^[1][4].
• Structural Heart Changes: Other reported findings include a patent ductus arteriosus (PDA) (a vessel that should close at birth) and abnormalities in the heart valves ^[1][5].

Lung and Respiratory Conditions

Lung issues can range from very mild to severe, and they are sometimes present even if a person doesn’t feel short of breath ^[6].

• Pulmonary Hypertension: This is high blood pressure in the arteries of the lungs, which can put a strain on the heart ^[3]. In severe cases, especially in infants, it can lead to respiratory failure ^[7][8].
• Lung Structure Changes: Some individuals develop emphysema (damaged air sacs) or other parenchymal changes (scars or densities in the lung tissue) ^[6][3]. Doctors recommend active baseline screening with lung function tests; further chest imaging is directed by specialists based on symptoms or findings, avoiding routine CT radiation where possible ^[6][3].

Other Systemic Manifestations

Because filamin A helps build connective tissue and blood cells, other symptoms are possible but variable:

• Connective Tissue: Many patients have joint hypermobility (being “double-jointed”) or skin that is extra stretchy or translucent ^[9][10].
• Gastrointestinal Issues: Severe constipation, intestinal malrotation (the bowel is not positioned correctly), or chronic pseudo-obstruction (symptoms of a blockage without a physical plug) have been reported ^[5][11].
• Blood and Clotting: Some people have macrothrombocytopenia (a low count of large platelets) ^[10], requiring individualized hematology or perioperative guidance before surgery or major dental work. Isolated cases of deep-vein thrombosis (DVT) or blood clots have also been reported, though routine clot screening is generally individualized ^[12].

Emergency Red Flags

While these events are uncommon, if you or your child have FLNA-related PVNH, the following symptoms require immediate emergency medical evaluation (call 911):

Recommended Monitoring

Specialist-directed care for FLNA-related PVNH often includes:

1. Baseline Screening: An echocardiogram and a vascular MRI (or CT, though MR angiography may be preferred in children) of the entire aorta at the time of diagnosis ^[15][4].
2. Ongoing Surveillance: Regular follow-ups with a cardiologist who specializes in aortopathies (diseases of the aorta). Interval and modality depend on initial measurements, age, and genetics ^[1][4].
3. Pulmonary Evaluation: Baseline pulmonary function testing, with echocardiography or imaging guided by symptoms ^[6][3].
4. Blood Counts: Checking platelet levels and getting perioperative guidance before any surgery or major dental work ^[2][10].